MONDAY, June 13, 2022 (HealthDay News) — An experimental drug for the neurological disorder ALS was approved in Canada on Monday, but an ongoing evaluation of the treatment by the U.S. Food and Drug Administration has raised questions about its effectiveness. A condition of Health Canada’s approval of Albrioza (AMX0035)Continue Reading

MONDAY, June 13, 2022 (HealthDay News) — One American city’s “radical” approach to handling low-level 911 calls — sending mental health professionals rather than police — may have taken a bite out of crime, a new study finds. The study evaluated Denver’s STAR program, which removed police from the responseContinue Reading

FRIDAY, June 10, 2022 (HealthDay News) — A form of diabetes caused by malnutrition is significantly different from type 1 or type 2 diabetes and should be considered a distinct form of the disease, a new study says. The findings may prove crucial in developing effective treatments for malnutrition-related diabetes,Continue Reading

WEDNESDAY, June 8, 2022 (HealthDay News) — There is a “staggering” gap between the number of Americans who need care for anxiety, depression and other mental health conditions and those who can actually get it, a new survey shows. In all, 42% of U.S. adults who needed care in theContinue Reading

TUESDAY, June 7, 2022 (HealthDay News) — High-tech devices and communication helped ease the impact of COVID-19 lockdowns on children with type 1 diabetes, researchers said in a new study. Pandemic shutdowns caused significant disruptions in health care, and previous studies have shown that diabetes patients had worse blood sugarContinue Reading